Ashleigh Palmer Insider Trading $UGNE UNIGENE LABORATORIES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ashleigh Palmer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ashleigh Palmer. Ashleigh Palmer is Chief Executive Officer in UNIGENE LABORATORIES INC ($UGNE) and President & CEO in UNIGENE LABORATORIES INC ($UGNE) and Director and CEO in Provention Bio, Inc. ($PRVB) and President & CEO in Provention Bio, Inc. ($PRVB) and President and CEO in Provention Bio, Inc. ($PRVB).
Ashleigh Palmer in UNIGENE LABORATORIES INC
Trading Symbol: UGNEIndustry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of Ashleigh Palmer: Chief Executive Officer, President & CEO
Holdings: 60,000 shares
Latest Transaction: Dec 11 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Ashleigh Palmer in UNIGENE LABORATORIES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 11 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | D | 0.25 | 660,000 | 165,000 | 3,000,000 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | A | 0.10 | 1,000,000 | 100,000 | 3,660,000 | |
Oct 01 2012 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | Chief Executive Off ... | Option Exercise | A | 0.25 | 660,000 | 165,000 | 2,660,000 | |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.53 | 7,500 | 3,975 | 60,000 | 52.5 K to 60 K (+14.29 %) |
Dec 22 2011 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.53 | 2,500 | 1,313 | 52,500 | 50 K to 52.5 K (+5.00 %) |
Sep 21 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.70 | 8,800 | 6,160 | 50,000 | 41.2 K to 50 K (+21.36 %) |
Aug 12 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.60 | 20,000 | 12,000 | 41,200 | 21.2 K to 41.2 K (+94.34 %) |
Jun 21 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.80 | 18,700 | 14,960 | 21,200 | 2.5 K to 21.2 K (+748.00 %) |
Jun 21 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Buy | P | 0.77 | 2,500 | 1,925 | 2,500 | 0 to 2.5 K |
Jun 17 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Option Exercise | A | 0.77 | 166,666 | 128,333 | 2,000,000 | |
Jun 17 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Option Exercise | A | 0.77 | 166,667 | 128,334 | 1,833,334 | |
Jun 17 2010 | UGNE | UNIGENE LABORATORI ... | Palmer Ashleigh | President & CEO | Option Exercise | A | 0.77 | 166,667 | 128,334 | 1,666,667 |
Page: 1